FEDERATED HERMES, INC. - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 164 filers reported holding ANIKA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$415,000
-85.4%
9,175
-88.6%
0.00%
-85.7%
Q3 2020$2,849,000
-5.8%
80,511
+0.4%
0.01%0.0%
Q2 2020$3,025,000
+302400.0%
80,174
+222605.6%
0.01%
Q1 2020$1,000
-88.9%
36
-77.2%
0.00%
Q3 2019$9,000
-94.1%
158
-94.4%
0.00%
Q4 2017$153,000
-48.1%
2,832
-44.3%
0.00%
-100.0%
Q3 2017$295,000
-36.3%
5,082
-45.8%
0.00%0.0%
Q2 2017$463,000
+18.1%
9,376
+4.0%
0.00%0.0%
Q1 2017$392,000
-56.6%
9,013
-51.2%
0.00%
-66.7%
Q4 2016$904,000
-42.8%
18,457
-44.1%
0.00%
-40.0%
Q3 2016$1,580,000
+25.4%
33,029
+40.6%
0.01%
+25.0%
Q2 2016$1,260,000
+10.2%
23,486
-8.1%
0.00%0.0%
Q1 2016$1,143,000
+114200.0%
25,555
+638775.0%
0.00%
Q4 2015$1,0000.0%40.0%0.00%
Q3 2015$1,000
-99.8%
4
-100.0%
0.00%
-100.0%
Q1 2015$561,000
+4.5%
13,629
+3.4%
0.00%0.0%
Q4 2014$537,000
+3.3%
13,178
-7.1%
0.00%0.0%
Q3 2014$520,000
-34.5%
14,184
-17.3%
0.00%0.0%
Q2 2014$794,000
+46.8%
17,142
+30.2%
0.00%0.0%
Q1 2014$541,000
+209.1%
13,163
+187.6%
0.00%
+100.0%
Q4 2013$175,000
+116.0%
4,577
+35.4%
0.00%
Q3 2013$81,000
+118.9%
3,380
+53.8%
0.00%
Q2 2013$37,0002,1970.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders